title: Perioperative chemotherapy versus adjuvant hormonal therapy in breast cancer: claimed benefits.
authors.forename: A Y
authors.initials: AY
authors.lastname: Rostom
authors.forename: A
authors.initials: A
authors.lastname: Ezzat
authors.forename: F
authors.initials: F
authors.lastname: Zwaan
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D017698:Postmenopause; D017697:Premenopause
chemical_list: D006728:Hormones; D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil